HOME >> MEDICINE >> NEWS
Cancer-fighting foods, supplements explored in day-long symposium, March 25

CHICAGO, March 25 Researchers worldwide are discovering a cornucopia of compounds in foods and dietary supplements that show promise for preventing cancer. More than a dozen research papers on this topic will be presented during a one-day symposium, Natural Products, Diets and Cancer Prevention, on Sunday, March 25, at the 233rd national meeting of the American Chemical Society.

All papers in this symposium are embargoed for 8:00 a.m. (Central Time), March 25. The symposium will be held at McCormick Place Lakeside, Room E264, Level 2.

Selected highlights are shown below:

Black raspberries show promise for preventing cancer of the esophagus, colon Using animal models (rodents) of cancer development, researchers at Ohio State University showed that animals whose diets were supplemented with black raspberries had a 60 percent reduction in tumors of the esophagus and up to an 80 percent reduction in colon tumors. Clinical trials are now underway to determine whether the berries will prevent the development of esophageal and colon cancer in humans, says study leader Gary D. Stoner, Ph.D., a researcher and professor of internal medicine at the university. (AGFD 008, Sunday, March 25, 8:45 a.m.)

Blueberries contain chemical that may help prevent colon cancer A compound found in blueberries shows promise in animal studies of preventing colon cancer, according to a joint study by scientists at Rutgers University and the U.S. Department of Agriculture. The compound, pterostilbene, is a potent antioxidant that could be developed into a pill with the potential for fewer side effects than some commercial drugs that are currently used to prevent the disease, according to study leader Bandaru Reddy, Ph.D., a professor in the Department of Chemical Biology at the university. (AGFD 009, Sunday, March 25, 9:15 a.m.) FULL NEWS RELEASE AVAILABLE.

Grape seed compounds may pr
'"/>


25-Mar-2007


Page: 1 2 3

Related medicine news :

1. Folic acid supplements do not appear to reduce risk of colorectal tumors
2. Some vitamin supplements dont protect against lung cancer
3. Vitamin D supplements may offer cheap and effective immune system boost against TB
4. Calcium plus vitamin D supplements may help prevent weight gain in postmenopausal women
5. Selenium supplements may contribute to reduced HIV viral load
6. Antenatal fish oil supplements boost kids hand-eye coordination
7. AASM position statement: Treating insomnia with over-the-counter sleep aids, herbal supplements
8. Calcium supplements fail to prevent bone fractures in children
9. Vitamin D supplements should be given to Asian children for two years from birth
10. Vitamin D and calcium supplements have varied effects on breast cancer risk
11. Calcium supplements may prevent fractures in elderly women who take them regularly

Post Your Comments:
(Date:4/24/2014)... from The University of Manchester have identified a way ... more open to treatment. , The study published today ... for the development of drugs to target cells that ... made the discovery whilst exploring the possible mechanisms behind ... treat breast and colon cancer. , Dr Andrew Gilmore, ...
(Date:4/24/2014)... with an antimicrobial peptide could help to lower the risk ... Optometry and Vision Science , official journal of the ... published by Lippincott Williams & Wilkins , a part ... and now humans support the biocompatibility and safety of lenses ... research by Debarun Dutta, B.Optom, of The University of New ...
(Date:4/24/2014)... new Institute for Biomedical Sciences at Georgia State ... grant to develop novel therapeutics against Respiratory Syncytial ... Eunice Kennedy Shriver National Institute Of Child Health ... Health will support Plemper,s drug development goals of ... distinct alternative compound. , Infections by RSV, a ...
(Date:4/24/2014)... than one out of three survivors of critical ... The Lancet Respiratory Medicine , and the ... than mentally. , It is one of the ... functional outcomes of critical care survivors, according to ... Medicine, and it highlights a significant public health ...
(Date:4/24/2014)... has found a relationship between motor skill deficiencies and ... in very young children. , The findings, believed ... relationship between motor skills and autism severity, indicate that ... included in treatment plans for young children with autism, ... of Public Health and Human Sciences. , "Recognizing ...
Breaking Medicine News(10 mins):Health News:Scientists find way to target cells resistant to chemo 2Health News:Study supports safety of antimicrobial peptide-coated contact lenses 2Health News:Study supports safety of antimicrobial peptide-coated contact lenses 3Health News:Vanderbilt study finds physical signs of depression common among ICU survivors 2Health News:Vanderbilt study finds physical signs of depression common among ICU survivors 3Health News:Motor skill deficiencies linked to autism severity in new research 2
(Date:1/15/2014)...  Echo Therapeutics, Inc. (Nasdaq: ECTE ) ("Echo"), ... as a non-invasive, wireless continuous glucose monitoring system, today ... and Interim CEO of Echo Therapeutics, will present at ... Mr. Doman will make a corporate ...
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com ... is available in its catalogue: ... Drug Forecast and Market Analysis to 2022 ... PharmaPoint: Atopic Dermatitis - India Drug Forecast ...
(Date:1/15/2014)... 15, 2014  Zafgen, Inc., a leading biopharmaceutical company ... obese patients, today announced initial results from its ... of methionine aminopeptidase 2 (MetAP2), in patients with ... obesity.  These results showed improvements in body weight, ...
Breaking Medicine Technology:Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4
Cached News: